COMMENTARY: Review: Effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy

Laville, Maurice
January 2008
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p12
Academic Journal
The author comments on the study about the treatment effects of angiotensin-converting enzyme (ACE) inhibitors in nondiabetic kidney disease. According to the author, heavy proteinuria is a significant factor in chronic kidney disease progression, but less evidence exists to show that ACE inhibitor-based therapy provides the same benefit to patients with non-proteinuric nephropathies.


Related Articles

  • Review: Effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p12 

    The article presents a study about the treatment effects of angiotensin-converting enzyme (ACE) inhibitors in nondiabetic kidney disease. Study shows that the effectiveness of ACE inhibitors does not differ across various baseline risks for disease progression in patients with nondiabetic...

  • Independent Nurse: Treatment based on beta-blockers could be phased out, trial suggests. Snow, Tamsin; Pownall, Mark // GP: General Practitioner;9/16/2005, p70 

    The article reports on a study which states that the use of beta-blockers as first-line therapy for uncomplicated hypertension is likely to become a thing of the past. The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) found that combination treatment with a calcium channel blocker and an ACE...

  • Angiotensin receptor blockers and risk of myocardial infarction: systematic review. McDonald, Michael A.; Simpson, Scot H.; Ezekowitz, Justin A.; Gyenes, Gabor; Tsuyuki, Ross T. // BMJ: British Medical Journal (International Edition);10/15/2005, Vol. 331 Issue 7521, p873 

    Objective To evaluate the effect of angiotensin receptor blockers on the risk of myocardial infarction in patients at risk for cardiovascular events. Design Systematic review of controlled trials of angiotensin receptor blockers. Data sources Medline, Embase, Cochrane central register of...

  • Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Hansen, Henrik P.; Nielsen, Flemming S.; Rossing, Peter; Jacobsen, Peter; Jensen, Berit R.; Parving, Hans-Henrik // Kidney International Supplement;Dec1997, Issue 63, pS49 

    Initiation of antihypertensive treatment in hypertensive non-insulin-dependent diabetic (NIDDM) patients with diabetic nephropathy induces a faster initial (0 to 6 months) and slower subsequent (6 months-end) decline in GFR [ΔGFR (ml · min-1 · 1.73 m-2 · month-1) approximately 1.5...

  • Start ACE inhibitors early, even in non-diabetic renal disease. Lau, Joseph // Modern Medicine;Nov97, Vol. 65 Issue 11, p10 

    Cites a report by Joseph Lau and colleagues published in the September 1, 1997 issue of the `Annals of Internal Medicine,' comparing the effectiveness of angiotensin-converting enzyme (ACE) inhibitors with antihypertensive drugs in reducing development of end-stage non-diabetic renal disease....

  • Fetal renin-angiotensin-system blockade syndrome: renal lesions. Plazanet, Caroline; Arrondel, Christelle; Chavant, François; Gubler, Marie-Claire // Pediatric Nephrology;Jul2014, Vol. 29 Issue 7, p1221 

    Background: Fetuses exposed to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists during the second and/or third trimesters of gestation are at high risk of developing severe complications. They consist in fetal hypotension, and anuria/oligohydramnios leading to Potter...

  • ACE-inhibitors unsafe in early pregnancy. Ford, Steve // Practice Nurse;7/7/2006, Vol. 32 Issue 1, p25 

    The article discusses research being done on the danger of taking angiotensin converting enzyme (ACE)-inhibitors in the first trimester of pregnancy. It references a study published in the 2006 issue of the New England Journal of Medicine. Researchers studied a cohort of infants born between...

  • Antihypertensive/NSAID triple therapy ups risk of kidney injury.  // Reactions Weekly;1/19/2013, Issue 1435, p2 

    The article focuses on a study which examined the association between the risk of acute kidney injury and triple therapy with two antihypertensives and a nonsteroidal anti-inflammatory drug (NSAID). Results of the study showed that a combination of diuretic, angiotensin converting enzyme (ACE)...

  • ACE inhibitors/antihypertensives interaction.  // Reactions Weekly;2/25/2012, Issue 1390, p5 

    The article describes the case of a male patient who developed hypotension, renal impairment and hyperkalaemia associated with interaction between angiotensin-converting enzyme (ACE) inhibitors and antihypertensives.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics